Xitabin
Xitabin 500 mg tablet is a nucleoside metabolic inhibitor with antineoplastic activity indicated for: Adjuvant Colon Cancer, Metastatic Colorectal Cancer, Metastatic Breast Cancer, Gastric, Esophageal, or Gastroesophageal Junction Cancer, and Pancreatic Cancer
Features
| Product Name | Xitabin |
| Generic Name | Capecitabine |
| Therapeutic Class | Antimetabolites |
| Formulation | Tablet |
| Available Pack Size | 5x6 |
| Available Strength | 500 mg |